×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
CDKN1C Antikörper (N-Term)
CDKN1C
Reaktivität: Human
WB, IF, EIA
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN1449989
Produktdetails anti-CDKN1C Antikörper
(ausblenden)
Target
Alle CDKN1C Antikörper anzeigen
CDKN1C
(Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
Bindungsspezifität
Alle Epitope für CDKN1C Antikörper
N-Term
Reaktivität
Alle Reaktivitäten für CDKN1C Antikörper
Human
Wirt
Alle Wirte für CDKN1C Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für CDKN1C Antikörper
Polyklonal
Konjugat
Alle Konjugate für CDKN1C Antikörper
Dieser CDKN1C Antikörper ist unkonjugiert
Applikation
Alle Applikationen für CDKN1C Antikörper
Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
Aufreinigung
Affinity chromatography purified via peptide column
Immunogen
A 17 amino acid synthetic peptide near the amino terminus of Human CDKN1C
Isotyp
IgG
Top Product
Discover our top product CDKN1C Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Konzentration
1.0 mg/mL
Buffer
PBS containing 0.02 % Sodium Azide as preservative
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Details zu CDKN1C
(ausblenden)
Target
CDKN1C
(Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
Andere Bezeichnung
CDKN1C / KIP2 (CDKN1C Produkte )
Synonyme
BWCR antikoerper, BWS antikoerper, KIP2 antikoerper, WBS antikoerper, p57 antikoerper, p57Kip2 antikoerper, cb961 antikoerper, p27Xic1-a antikoerper, zgc:86618 antikoerper, AL024410 antikoerper, CDKI antikoerper, Kip2 antikoerper, p57(kip2) antikoerper, p57KIP2 antikoerper, cyclin dependent kinase inhibitor 1C antikoerper, cyclin-dependent kinase inhibitor 1Ca antikoerper, cyclin-dependent kinase inhibitor 1C (P57) antikoerper, cyclin-dependent kinase inhibitor 1C antikoerper, CDKN1C antikoerper, cdkn1ca antikoerper, Cdkn1c antikoerper
Hintergrund
The cyclin-dependent kinase inhibitor 1C (CDKN1C), also known as p57KIP2, is a tight-binding, strong inhibitor of several G1 cyclin/CDK complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndrome, a cancer-predisposing syndrome, suggesting that this gene is a tumor suppressor candidate. CDKN1C is widely expressed during organogenesis with its expression declining after maturity. It is part of the CIP/KIP family of cyclin-dependent inhibitors (CKIs) which also includes CDKN1A and CDKN1B.Synonyms: Cyclin-dependent kinase inhibitor 1C, Cyclin-dependent kinase inhibitor p57, p57KIP2
Molekulargewicht
35 kDa
Gen-ID
1028
NCBI Accession
NP_000067
Pathways
Zellzyklus , Dopaminergic Neurogenesis
Zuletzt angesehen
(ausblenden)